| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996205532103316 |
|
|
Titolo |
Cardiac CT, PET and MR [[electronic resource] /] / edited by Vasken Dilsizian and Gerald M. Pohost ; foreword by Robert O. Bonow |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Malden, MA, : Blackwell Futura, 2006 |
|
|
|
|
|
|
|
ISBN |
|
1-280-74814-1 |
9786610748143 |
0-470-98853-3 |
1-4051-7171-5 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (274 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
DilsizianVasken |
PohostGerald M |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Cardiovascular system - Imaging |
Cardiovascular system - Tomography |
Cardiovascular system - Magnetic resonance imaging |
Tomography, Emission |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Cardiac CT, PET and MR; Contents; Contributors; Foreword; Part I: Instrumentation, imaging techniques, and protocols; 1. Positron emission tomography; 2. Cardiovascular magnetic resonance: Basic principles, methods and techniques; 3. Multidetector and electron-beam computed tomography of the heart; Part II: Clinical applications; 4. PET assessment of myocardial perfusion; 5. PET: Metabolism, innervation and receptors; 6. MR angiography: Coronaries and great vessels; 7. Cardiovascular magnetic resonance: Evaluation of myocardial function, perfusion and viability; 8. MSCT coronary imaging |
9. Cardiac computed tomography: Evaluation of myocardial function, perfusion and viabilityPart III: Concurrent noninvasive assessment of coronary anatomy, physiology, and myocellular integrity; 10. PET and MRI in cardiac imaging; 11. PET and CT in cardiac imaging: Is a paradigm shift from SPECT to hybrid PET/CT inevitable?; Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
The standard procedure for defining the anatomic extent and severity of coronary artery disease is catheter-based selective coronary |
|
|
|
|
|
|
|
|
|
|
|
|
|
angiography. While there are advantages to coronary angiography, it is invasive with some risk of complications and requires a brief period of hospitalization, making it relatively expensive. Cardiac CT, PET and MR is a complete technique-oriented reference, offering real alternatives to the "standard procedure". Non-invasive techniques of coronary artery lumen imaging, such as multislice computed tomography (MSCT) and magnetic resonance imaging (CMR |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910787308103321 |
|
|
Titolo |
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, District of Columbia : , : National Academies Press, , [2012] |
|
©2012 |
|
|
|
|
|
|
|
|
|
ISBN |
|
0-309-26119-8 |
0-309-26117-1 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (132 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Drug monitoring |
Drug development - United States |
Drugs - United States - Design |
Pharmaceutical industry - United States - Quality control |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (pages 71). |
|
|
|
|
|
|
Nota di contenuto |
|
Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description. |
|
|
|
|
|
|
|
| |